Drug Profile
Isoniazid - Only For Children Pharmaceuticals
Latest Information Update: 11 Dec 2021
Price :
$50
*
At a glance
- Originator Only for Children Pharmaceuticals
- Class Antibacterials; Antituberculars; Carboxylic acids; Hydrazines; Isonicotinic acids; Small molecules
- Mechanism of Action Cell wall inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Tuberculosis
Most Recent Events
- 28 Jan 2018 No recent reports of development identified for research development in Tuberculosis in France (PO, Liquid)
- 31 Dec 2013 Early research in Tuberculosis in France (PO)